Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis

Neil Gittoes

Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis

Metabolism and Systems Research

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Bone
Publication status	Accepted/In press - 3 Oct 2019

Cite this

@article{0ff356e4724f4dc58c0884b1f06476c4,

title = "Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: a systematic review and network meta-analysis",

author = "Neil Gittoes",

year = "2019",

month = oct,

day = "3",

language = "English",

journal = "Bone",

issn = "8756-3282",

publisher = "Elsevier",

}